123 related articles for article (PubMed ID: 7882575)
1. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys.
Seymour AA; Asaad MM; Abboa-Offei B; Smith PL; Rogers WL
Clin Exp Pharmacol Physiol; 1994 Nov; 21(11):845-56. PubMed ID: 7882575
[TBL] [Abstract][Full Text] [Related]
2. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
[TBL] [Abstract][Full Text] [Related]
6. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
7. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
[TBL] [Abstract][Full Text] [Related]
8. Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Mathers PD; Rogers WL; Dorso CR
J Cardiovasc Pharmacol; 1996 Nov; 28(5):651-8. PubMed ID: 8945678
[TBL] [Abstract][Full Text] [Related]
9. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
Seymour AA; Mathers PD; Abboa-Offei BE; Asaad MM; Weber H
J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
Legault L; Cernacek P; Levy M; Maher E; Farber D
J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
[TBL] [Abstract][Full Text] [Related]
12. Amplification by atrial natriuretic peptide of the haemodynamic and renal responses to an acute volumic stress in the rat.
Caron N; Simon F; Plennevaux F; Michel A; Kramp R
Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):315-22. PubMed ID: 10225142
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
Seymour AA; Fennell SA; Swerdel JN
Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase.
Seymour AA; Swerdel JN; Fennell SA; Druckman SP; Neubeck R; Delaney NG
J Cardiovasc Pharmacol; 1989 Aug; 14(2):194-204. PubMed ID: 2476591
[TBL] [Abstract][Full Text] [Related]
15. Role of atrial natriuretic peptide in sodium balance in conscious spontaneously hypertensive rats.
Seymour AA; Swerdel JN; Fennell SA; Kratunis VJ; Asaad MM
Am J Physiol; 1990 Apr; 258(4 Pt 2):F916-26. PubMed ID: 2139545
[TBL] [Abstract][Full Text] [Related]
16. Renal denervation potentiates the natriuretic and diuretic effects of atrial natriuretic peptide in anaesthetized rabbits.
Christy IJ; Denton KM; Anderson WP
Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):41-8. PubMed ID: 8156651
[TBL] [Abstract][Full Text] [Related]
17. Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 May; 106(1):180-6. PubMed ID: 1387023
[TBL] [Abstract][Full Text] [Related]
18. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
Campbell HT; Lightfoot BO; Sklar AH
Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in chronically hypertensive dogs.
Seymour AA; Asaad MM; Sheldon JH; Smith PL; Rogers WL
Hypertension; 1995 Oct; 26(4):634-41. PubMed ID: 7558224
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide is involved in renal actions of moxonidine.
Mukaddam-Daher S; Gutkowska J
Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
